Worsening hair loss in post-COVID patients: Literary review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i16.38311

Keywords:

COVID-19; Telogen effluvium; Mesotherapy; Loos of hair.

Abstract

In 2020, the world was affected by the COVID-19 pandemic known as severe acute respiratory syndrome. However, there is a perception that the manifestations of COVID go far beyond the lungs, such as the nervous system and dermatological problems. Among the dermatological sequelae of the disease, it appears that there is a hair loss described in the literature. The purpose of this article is to look for a relationship between hair loss and COVID-19. The telogen effluvium sequel to COVID-19 occurs even after the patient has recovered. With regard to treatments, we considered the search terms of other articles, studies show that in addition to primary treatments such as reducing stress or triggering event, there are also several aesthetic treatments. Such as mesotherapy (intradermotherapy) which consists of applications of pharmacological substances. Microneedling associated with the use of drug delivery is a technique that involves a roller with microneedles that cause small microperforations that cross the stratum corneum, facilitating the penetration of the active ingredients. Carboxytherapy consists of the use of medicinal carbonic gas, where subcutaneous application occurs using a device with a very fine needle. The laser consists of using a device with a beam of light that will be launched into the hair bulb, for the treatment of alopecia. Therefore, all these treatment factors are of paramount importance to obtain control of hair loss after COVID-19, and the best thing to do is to seek a professional so that the treatment is more assertive and individual.

References

Abrantes, T. F. (2021). Time of onset and duration of post-COVID-19 acute telogen effluvium. American Academy of Dermatology Association, 85(4), 975-976. https://doi.org/https://www.jaad.org/article/S0190-9622(21)02149-6/fulltext

Araújo, V. C. (2022). Telogen Effluvium after SARS-CoV-2 infection: a narrative review of physiological mechanism. Brazilian Journal of Health Review, 5(3). https://doi.org/doi:10.34119/bjhrv5n3-181

Cristiano, A. B. (2022). Physical and emotional impact on people with telogen effluvium post-COVID-19 infection. BWS Journal, 5(1), 1-12. https://doi.org/https://bwsjournal.emnuvens.com.br/bwsj/article/view/358/193

Cutaneous Manifestations Associated with Covid-19 According to Literature Published Until 04/30/21. (2021, April 30). Sociedade Brasileira de Dermatologia, 1-10. https://doi.org/file:///C:/Users/hytal/Downloads/nota-tecnicasbd.pdf

Gomes de Carvalho, C. (2021). Aesthetic Biomedicine and The Contributions of Treatment Against Hair Loss with Plasma Rich in Platelets Post Covid-19. Recisatec - Scientific Journal Health and Technology- ISSN 2763-8405, 1(2), e1213. https://doi.org/10.53612/recisatec.v1i2.13

Gress, J. B. (2022). Telogen Effluvium after COVID-19 infection. Um Revisão Narrativa Brazilian Journalof Health Review, 5 (2), 2595-6825. https://brazilianjournals.com/ojs/index.php/BJHR/article/view/45408

Gubert, L. C. (2017). Tratamento Da Alopecia Androgenética Associando O Uso De Minoxidil À Técnica De Microagulhamento: Relato De Caso. Unijuí universidade regional, 1-24. https://doi.org/https://bibliodigital.unijui.edu.br:8443/xmlui/bitstream/handle/123456789/4757/Larissa%20Gubert.pdf?sequence=1&isAllowed=y

Habas, K. (2020). Coronavirus disease resolution 2019 (COVID-19). Taylor e Francis Online, 18(12), 1201-1211. https://doi.org/https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1797487

Hu, B. (2022). Characteristics of Sars-Cov-2 and COVID-19. Nature reviews microbiology, 19, 141-154. https://doi.org/https://www.nature.com/articles/s41579-020-00459-7

Hussain, N. (2021, December 19). A review of a distressing post- COVID-19 protster, Journal of Medical Virology,94(4), 1391-1401.https://onlinelibrary.wiley.com/doi/10.1002/jmv.27534

Izumi, M. d. O. (2021). Treatment of Post- COVID-19 Telogen Effluvium. BWS Journal, 4, 1-8. https://doi.org/https://bwsjournal.emnuvens.com.br/bwsj/article/view/165/98

Lima, P. C (2022). Acute telogen effluvium and alopecia areata associated with COVID-19. Bws journal, 5 (1), 1-9. https://bwsjournal.emnuvens.com.br/bwsj/article/view/273/141

Meneses, A. S. (2020). Natural History COVID-19 and its therapeutic relationships. SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.733

Mieczkowska, K. (2021). Telogen Eflluvium: A sequel to COVID-19. International jornal of Dermatology, 60(1), 122-124. https://onlinelibrary.wiley.com/doi/10.1111/ijd.15313

Regina, S. (2017). O Estudo de caso como método de pesquisa em enfermagem: Uma revista integrativa. Scielo, 1-12.

Rizzetto, G. (2020). Telogen Effluvium Related to Sars-Cov-2 Infection Clinical aspects and our management experience Dermatologic Therapy, 34(1), 1-6. https://onlinelibrary.wiley.com/doi/10.1111/dth.14547

Sarmento, R. G. (2020). Hair Therapy of Male Androgenetic alopecia with the use of laser low potency associated with essencial oils. Id no Line Revista Multidisciplinar e de Psicologia, 14(53), 463-473. file:///C:/Users/hytal/Downloads/d2b2e1a1a5802e067ae044bfd6921d63

Seyfi, S . (2022). Prevalence of telogen effluvium hair loss in patients with COVID-19 and its relationship with disease severity, 15(5), 1-6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262270/#!po=56.2500

Silva, A. P. (2021). Low seif-esteem hair loss caused by COVID-19. Revista de Saúde, meio ambiente, e sustentabilidade, 16 (198094), 185-198. https://www.researchgate.net/profile/Isabella-Barbosa-2/publication/356816008_Baixa_autoestima_a_queda_de_cabelo_provocada_pela_Covid19_Low_self-esteem_hair_loss_caused_by_Covid19/links/61aeb782fb3b7258a0a250d5/Baixa-autoestima-a-queda-de-cabelo-provocada-pela-Covid19-Low-self-esteem-hair-loss-caused-by-Covid19.pdf?origin=publication_detail

Silva, M. I. (2017). Approaches of aesthetic pharmacy inthe treatment of androgenetic alopecia. Saúde Batatais, 6(2), 73-82. file:///C:/Users/hytal/Downloads/605b7272b96e769217678063.pdf

Simplício, P. C. (2018). Carboxytherapy in the treatment of alopecia. Faculdade Ávila. file:///C:/Users/hytal/Downloads/80_-_Carboxiterapia_no_tratamento_da_alopecia_1.pdf

Umakanthan, S. (2020). Origin Transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). BML Journals, 96, 753-758. https://pmj.bmj.com/content/96/1142/753.long

Wu, M. (2021). Post-Covid-19 syndrome-Literature Review: Cautions After Covid-19 symptons improvement. Biociências, 27(1), 1-14. https://doi.org/http://periodicos.unitau.br/ojs/index.php/biociencias/article/download/3313/2034/12109

Zhang, Y. (2020). SARS- CoV-2 -Induced Telógeno effluvium: a multicentric Study. Jornal da Acadamia Europeia de Dermatologia e Venereologia, 35(3), 18-183. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17045

Published

12/12/2022

How to Cite

ALMEIDA, A. C. S. S. de .; NECA, C. S. M. .; SILVA, F. S. R. .; CARVALHO , T. A. de .; VIEGAS, Y. E. F. . Worsening hair loss in post-COVID patients: Literary review. Research, Society and Development, [S. l.], v. 11, n. 16, p. e396111638311, 2022. DOI: 10.33448/rsd-v11i16.38311. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/38311. Acesso em: 14 nov. 2024.

Issue

Section

Health Sciences